0.00
Springworks Therapeutics Inc Borsa (SWTX) Ultime notizie
Is SpringWorks Therapeutics Inc. stock overvalued or undervaluedMaximize your returns with portfolio optimization - jammulinksnews.com
How does SpringWorks Therapeutics Inc. compare to its industry peersGet exclusive access to professional stock picks - jammulinksnews.com
What institutional investors are buying SpringWorks Therapeutics Inc. stockBuild wealth faster with consistent growth stocks - jammulinksnews.com
What drives SpringWorks Therapeutics Inc. stock priceFree Market Volatility Navigation Tips - jammulinksnews.com
SpringWorks Therapeutics Inc. Stock Analysis and ForecastGet alerts on high-potential market moves - jammulinksnews.com
Merck KGaA’s $3.9 Billion Springworks Deal to Boost US Presence - MSN
How volatile is SpringWorks Therapeutics Inc. stock compared to the marketEarnings Report Opportunities To Watch Now - jammulinksnews.com
Should I hold or sell SpringWorks Therapeutics Inc. stock in 2025Value Investing Data Feed For Beginners - jammulinksnews.com
What catalysts could drive SpringWorks Therapeutics Inc. stock higher in 2025Stock Market Recommendation With Low Risk - jammulinksnews.com
Published on: 2025-07-30 08:30:59 - metal.it
Published on: 2025-07-29 02:19:36 - beatles.ru
Sentiment Tools Show Shift in Trader Mood on SpringWorks Therapeutics Inc.Conservative Entry for High Return Setup Backed - metal.it
What makes SpringWorks Therapeutics Inc. stock price move sharplyEarly Breakout Entry Point Notifications Sent - metal.it
Is SpringWorks Therapeutics Inc. a growth stock or a value stockUnlock exclusive stock market forecasts - jammulinksnews.com
What are SpringWorks Therapeutics Inc. company’s key revenue driversAchieve breakthrough investment performance - jammulinksnews.com
Why SpringWorks Therapeutics Inc. stock attracts strong analyst attentionEarly Breakout Tracker - metal.it
Is SpringWorks Therapeutics Inc. a good long term investmentFree Market Volatility Navigation Tips - PrintWeekIndia
What analysts say about SpringWorks Therapeutics Inc. stockFree Investment Community - PrintWeekIndia
Neurofibromatosis Type 2 Pipeline 2025: MOA and ROA Insights, - openPR.com
SpringWorks Therapeutics (SWTX) Surged on Acquisition News - MSN
European Commission Grants Conditional Approval for SpringWorks Therapeutics' EZMEKLY® to Treat Plexiform Neurofibromas in NF1 Patients - Nasdaq
European Commission Grants Conditional Approval of EZMEKLY® - GlobeNewswire
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN - Yahoo Finance
California Rep. Gilbert Ray Cisneros Sold Over $28K Worth of SpringWorks Therapeutics Inc Ordinary Shares Stock: Here's What You Should Know - Nasdaq
Principal Financial Group Inc. Decreases Stock Position in SpringWorks Therapeutics (NASDAQ:SWTX) - MarketBeat
CIBRA Capital Ltd Purchases New Holdings in SpringWorks Therapeutics (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics - Hartford Business Journal
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):